Cargando…
Analysis of m6A-Related lncRNAs for Prognosis Value and Response to Immune Checkpoint Inhibitors Therapy in Hepatocellular Carcinoma
INTRODUCTION: N6-methyladenosine (m6A) modification and long non-coding RNAs (lncRNAs) play pivotal roles in the progression of hepatocellular carcinoma (HCC). However, how their interaction is involved in the prognostic value of HCC and immune checkpoint inhibitors (ICIs) therapy remains unclear. M...
Autores principales: | Wang, Yi, Li, Na, Tian, Di, Zhou, Chang-Wu, Wang, You-Hua, Yang, Chun, Zeng, Meng-Su |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379396/ https://www.ncbi.nlm.nih.gov/pubmed/34429653 http://dx.doi.org/10.2147/CMAR.S322179 |
Ejemplares similares
-
Cuproptosis- and m6A-Related lncRNAs for Prognosis of Hepatocellular Carcinoma
por: Zhu, Yuezhi, et al.
Publicado: (2023) -
Network of clinically-relevant lncRNAs-mRNAs associated with prognosis of hepatocellular carcinoma patients
por: Lim, Lee Jin, et al.
Publicado: (2020) -
Diagnosis, prognosis and bioinformatics analysis of lncRNAs in hepatocellular carcinoma
por: Dai, Meiyu, et al.
Publicado: (2017) -
Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer
por: Wang, Yi, et al.
Publicado: (2022) -
Analysis of the role of m6A and lncRNAs in prognosis and immunotherapy of hepatocellular carcinoma
por: Xu, Yan, et al.
Publicado: (2022)